Dendritic cell vaccination against ovarian cancer–tipping the Treg/TH17 balance to therapeutic advantage?

Enhanced stimulation of anti-ovarian cancer CD8(+) T cells by dendritic cells loaded with nanoparticle encapsulated tumor antigen

[Study on the specific immunity induced by dendritic cell vaccine loading allogenic microvascular endothelial cell bEnd.3 antigen against U14 cervical cancer cell in mice]

Induction of cellular immune responses in patients with stage-I multiple myeloma after vaccination with autologous idiotype-pulsed dendritic cells

Sipuleucel-T: in metastatic castration-resistant prostate cancer

New perspectives in glioma immunotherapy

Gene carriers and transfection systems used in the recombination of dendritic cells for effective cancer immunotherapy

Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in patients with recurrent malignant glioma

Guiding the „misguided“ – functional conditioning of dendritic cells for the DC-based immunotherapy against tumours